tiprankstipranks
Savencia SA (FR:SAVE)
:SAVE
Want to see FR:SAVE full AI Analyst Report?

Savencia (SAVE) AI Stock Analysis

4 Followers

Top Page

FR:SAVE

Savencia

(SAVE)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 5.2)
Rating:56Neutral
Price Target:
€65.00
▲(2.85% Upside)
Action:Reiterated
Date:08/06/26
The score is primarily held back by weakening 2025 fundamentals (lower revenue, thinner profitability, and poorer cash conversion) and bearish technical momentum. A reasonable valuation (P/E ~11 and ~2.2% dividend yield) partially offsets these risks but does not outweigh the recent operational and trend deterioration.
Positive Factors
Manageable leverage
Moderate leverage gives Savencia a reasonable balance-sheet foundation for a packaged-food business. Stable equity and debt-to-equity below 1.0 preserve flexibility to absorb operating volatility and fund ongoing activities.
Negative Factors
Recent revenue contraction
The 2025 sales decline interrupts the prior growth trajectory and may signal weaker volumes, mix, or customer demand. Persistent contraction would reduce operating leverage and make it harder to spread manufacturing and distribution costs.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable leverage
Moderate leverage gives Savencia a reasonable balance-sheet foundation for a packaged-food business. Stable equity and debt-to-equity below 1.0 preserve flexibility to absorb operating volatility and fund ongoing activities.
Read all positive factors

Savencia (SAVE) vs. iShares MSCI France ETF (EWQ)

Savencia Business Overview & Revenue Model

Company Description
Savencia SA is a French-headquartered enterprise, established in 1956, specializing in the production of dairy items for both domestic and international markets. The company's product portfolio encompasses a diverse range of cheeses, along with bu...
How the Company Makes Money
Savencia makes money primarily by producing and selling dairy and cheese products through two main routes: (1) branded consumer products sold to retail channels and (2) specialty/ingredient products sold to professional customers. In its consumer ...

Savencia Financial Statement Overview

Summary
Financials indicate stability but weakening near-term performance: 2025 revenue declined (-2.8% YoY), EBIT/EBITDA margins compressed, and net margin remained very thin (~1.1%). Leverage is manageable (debt-to-equity ~0.74), but cash conversion deteriorated with operating cash flow down and free cash flow covering only ~19% of net income in 2025.
Income Statement
56
Neutral
Balance Sheet
62
Positive
Cash Flow
50
Neutral
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue6.96B7.14B6.79B6.55B5.61B
Gross Profit2.36B2.41B2.21B279.49M291.00M
EBITDA405.54M464.55M412.74M373.25M372.31M
Net Income74.70M106.97M96.48M68.05M82.94M
Balance Sheet
Total Assets4.88B4.95B4.65B4.58B4.32B
Cash, Cash Equivalents and Short-Term Investments684.84M753.34M636.14M572.63M572.62M
Total Debt1.24B1.21B1.19B1.08B1.09B
Total Liabilities2.94B2.96B2.83B2.76B2.62B
Stockholders Equity1.68B1.74B1.58B1.59B1.48B
Cash Flow
Free Cash Flow59.45M138.77M81.70M66.65M72.36M
Operating Cash Flow313.85M386.89M260.61M255.05M301.79M
Investing Cash Flow-427.70M-243.88M-236.29M-196.95M-230.59M
Financing Cash Flow-108.28M-10.74M28.18M-59.01M-120.07M

Savencia Technical Analysis

Technical Analysis Sentiment
Negative
Last Price63.20
Price Trends
50DMA
65.43
Negative
100DMA
65.24
Negative
200DMA
61.73
Positive
Market Momentum
MACD
-0.20
Negative
RSI
45.69
Neutral
STOCH
21.38
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:SAVE, the sentiment is Negative. The current price of 63.2 is below the 20-day moving average (MA) of 64.22, below the 50-day MA of 65.43, and above the 200-day MA of 61.73, indicating a neutral trend. The MACD of -0.20 indicates Negative momentum. The RSI at 45.69 is Neutral, neither overbought nor oversold. The STOCH value of 21.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:SAVE.

Savencia Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
€4.02B12.2212.95%1.35%15.18%31.78%
62
Neutral
€42.59B21.7411.13%3.21%0.46%6.19%
57
Neutral
€89.85M31.866.80%5.18%3.64%-71.49%
56
Neutral
€875.02M11.134.46%2.22%-2.56%-28.90%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
38
Underperform
€280.08M5.693.60%2.93%-3.63%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:SAVE
Savencia
63.80
2.59
4.23%
FR:BON
Bonduelle
8.71
0.72
8.96%
FR:BN
DANONE SA
66.32
-3.93
-5.59%
FR:ALFLE
Fleury Michon
21.50
-2.61
-10.84%
FR:LOUP
Societe LDC Societe Anonyme
112.20
20.95
22.96%
FR:SABE
Saint Jean Groupe SA
20.20
1.30
6.88%

Savencia Corporate Events

Savencia Updates Share Capital and Voting Rights as of July 2026
Aug 10, 2026
Savencia reported that as of July 31, 2026, its share capital consisted of 14,032,930 shares in issue, reflecting the current equity base of the group. The company also disclosed a total of 23,887,915 theoretical voting rights and 22,755,181 net v...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 06, 2026